Home
Conditions
Infections, Bacterial

Clinical trial condition

Infections, Bacterial

Explore clinical trials studying Infections, Bacterial. Study availability and eligibility vary by location and protocol.

39 public trials 5 recruiting studies

Refine in advanced search Browse all conditions

Infections, Bacterial trial results

Completed

Effect of Raxibacumab on Immunogenicity of Anthrax Vaccine Adsorbed

NCT02339155

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Infections, +1 more
Locations: GSK Investigational Site Edgewater, Florida, United States

GSK Investigational Site Overland Park, Kansas, United States

GSK Investigational Site Knoxville, Tennessee, United States

View Trial Details

Completed

Effect of BPA on Anchor Antibiotic Continuity in the ED: Randomized Controlled Trial

NCT04620486

Conditions: Alert Fatigue, Health Personnel, Bacterial Infections, Bacterial Infections and Mycoses, +12 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Drug-drug Interaction Study of Gepotidacin

NCT04493931

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Infections, +1 more
Locations: GSK Investigational Site Las Vegas, Nevada, United States

View Trial Details

Completed

Pharmacokinetics (PK) Study of Gepotidacin (GSK2140944) in Adult Subjects With Varying Degrees of Hepatic Impairment and in Matched Control Subjects With Normal Hepatic Function

NCT03562117

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Infections, +1 more
Locations: GSK Investigational Site Miami, Florida, United States

GSK Investigational Site Orlando, Florida, United States

View Trial Details

Completed

To Assess Bioavailability, Food Effect and Pharmacokinetics of Gepotidacin Tablets: A Phase I, Single-Dose, 2 Part Study in Healthy Subjects.

NCT02853435

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Infections, +1 more
Locations: GSK Investigational Site Anaheim, California, United States

GSK Investigational Site Austin, Texas, United States

View Trial Details

Completed

Pharmacokinetics of Gepotidacin Tablets in Adults and Adolescents Subjects

NCT04079790

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Infections, +1 more
Locations: GSK Investigational Site Las Vegas, Nevada, United States

View Trial Details

Completed

Pharmacokinetic Study of Gepotidacin in Subjects With Varying Degrees of Renal Impairment and in Subjects With Normal Renal Function

NCT02729038

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Chronic Disease, +14 more
Locations: GSK Investigational Site Miami, Florida, United States

GSK Investigational Site Orlando, Florida, United States

GSK Investigational Site Minneapolis, Minnesota, United States

View Trial Details

Completed

Pharmacokinetic Study of Oral Gepotidacin (GSK2140944) in Subjects With Uncomplicated Urinary Tract Infection (Acute Cystitis)

NCT03568942

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Female Urogenital Diseases, +7 more
Locations: GSK Investigational Site La Mesa, California, United States

View Trial Details

Completed

Bioequivalence Study Between SKF101804 Cefixime 200 Milligram (mg)/5 Milliliter (mL) Suspension Versus Cefixime 200 mg/5 mL Suspension Reference Product in Healthy Adult Subjects Under Fasting Conditions

NCT03408392

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Infections, +1 more
Locations: GSK Investigational Site Bloemfontein, Free State, South Africa

View Trial Details

Completed

Bioequivalence Study Between GR37547 500 Milligrams (mg) Tablet Versus Ciprofloxacin 500 mg Tablet Reference Product in Healthy Adult Subjects

NCT03150082

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Infections, +1 more
Locations: GSK Investigational Site Bloemfontein, South Africa

View Trial Details

Infections, Bacterial

Infections, Bacterial trial results

Related conditions